Andrew P. Degnan - Concepedia

Author

Andrew P. Degnan

Bristol-Myers Squibb (United States)ORCID

Also Known As

A. P. DEGNAN, Andrew Degnan, Andrew P Degnan, Andrew P. Degnan, Degnan, Andrew P.

Publications

835

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Pennsylvania Bristol-Myers Squibb (Germany)Colorado State University Monell Chemical Senses Center

About

Andrew P. Degnan is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	6	6	304
2	Natural Sciences	5	5	276
3	Medicine	4	4	81
4	Biomolecular Engineering	3	3	148
5	Engineering	2	2	120

Andrew P. Degnan

Publications

784

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis of (+)-13-Deoxytedanolide Amos B. Smith, Christopher M. Adams, Stephanie A. Barbosa, Journal of the American Chemical Society Enantioselective SynthesisBioorganic ChemistryBiochemistryNatural SciencesMethyl Ketone 4	2002	114
Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes Laura T. Haas, Santiago V. Salazar, Levi M. Smith, Cell Reports	2017	107
Total Syntheses of (−)-Herbertenediol, (−)-Mastigophorene A, and (−)-Mastigophorene B. Combined Utility of Chiral Bicyclic Lactams and Chiral Aryl Oxazolines Andrew P. Degnan, A. I. MEYERS Journal of the American Chemical Society EngineeringOrganic ChemistryChemistryHeterocycle ChemistryChiral Bicyclic Lactams	1999	93
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor Dan You, Stephen Hillerman, Gregory Locke, Journal for ImmunoTherapy of Cancer	2021	75
Discovery of (<i>R</i>)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-<i>N</i>-(3-(7-methyl-1<i>H</i>-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure Andrew P. Degnan, Prasad V. Chaturvedula, Charles M. Conway, Journal of Medicinal Chemistry	2008	59
A unified approach to the tedanolides: Total synthesis of (+)-13-deoxytedanolide Amos B. Smith, Christopher M. Adams, Stephanie A. Barbosa, Proceedings of the National Academy of Sciences	2004	59
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1 Andrew P. Degnan, Godwin Kumi, Christopher W. Allard, ACS Medicinal Chemistry Letters	2021	51
Enantioselective Synthesis of Rigid 2-Aminotetralins. Utility of Silicon as an Oxygen and Nitrogen Surrogate in the Tandem Addition Reaction Andrew P. Degnan, A. I. MEYERS The Journal of Organic Chemistry	2000	31
Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5 Fukang Yang, Lawrence B. Snyder, Anand Balakrishnan, ACS Medicinal Chemistry Letters Drug TargetPsychotropic MedicationMglur5 SubtypePharmacotherapyChemical Biology	2016	28
Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box Hong Huang, Andrew P. Degnan, Anand Balakrishnan, Bioorganic & Medicinal Chemistry Letters Oxazolidinone-based Allosteric ModulatorsMolecular PharmacologyBiochemistryDefining Molecular SwitchesMedicine	2016	28

Page 1